How has been the historical performance of Bayer CropSci.?

Sep 23 2025 10:42 PM IST
share
Share Via
Bayer CropSci. has experienced steady growth in net sales, reaching 5,473.40 Cr in March 2025, but faced declining profitability with operating profit dropping to 809.30 Cr and a significant decrease in cash flow, resulting in a net cash outflow of 271.00 Cr. Total assets and liabilities increased, driven by higher inventories.
Answer:
The historical performance of Bayer CropSci. shows a steady increase in net sales, reaching 5,473.40 Cr in March 2025, up from 5,106.20 Cr in March 2024 and 5,139.70 Cr in March 2023. The total operating income followed a similar trend, with a notable rise to 5,473.40 Cr in March 2025. However, the operating profit (PBDIT) decreased to 809.30 Cr in March 2025 from 1,035.00 Cr in March 2024, indicating a decline in profitability despite higher sales. Profit before tax also saw a decrease to 707.40 Cr in March 2025 from 941.40 Cr in March 2024, while profit after tax fell to 568.00 Cr from 740.50 Cr in the same period.

On the balance sheet, total assets increased to 5,236.20 Cr in March 2025 from 4,597.10 Cr in March 2024, driven by a rise in current assets, particularly inventories, which reached 2,361.80 Cr. Total liabilities also rose to 5,236.20 Cr in March 2025, reflecting an increase in current liabilities. Cash flow from operating activities decreased significantly to 262.00 Cr in March 2025 from 951.00 Cr in March 2024, contributing to a net cash outflow of 271.00 Cr in March 2025. Overall, while Bayer CropSci. has shown growth in sales and assets, profitability and cash flow have faced challenges in the latest fiscal year.

Breakdown:
Bayer CropSci. has demonstrated a consistent upward trajectory in net sales over the years, culminating in 5,473.40 Cr in March 2025, which is an increase from previous years. Despite this growth in sales, the operating profit (PBDIT) has seen a decline, dropping to 809.30 Cr in March 2025 from 1,035.00 Cr in March 2024, indicating a potential issue with cost management or operational efficiency. The profit before tax also decreased to 707.40 Cr, reflecting a broader trend of declining profitability, as profit after tax fell to 568.00 Cr. On the balance sheet, total assets rose to 5,236.20 Cr, driven by increased inventories, while total liabilities rose correspondingly. The cash flow from operating activities has significantly decreased to 262.00 Cr, resulting in a net cash outflow of 271.00 Cr, highlighting challenges in cash generation despite higher sales figures.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Bayer CropSci. falling/rising?
Nov 11 2025 10:56 PM IST
share
Share Via
How has been the historical performance of Bayer CropSci.?
Nov 09 2025 10:41 PM IST
share
Share Via
Are Bayer CropSci. latest results good or bad?
Nov 08 2025 07:19 PM IST
share
Share Via
Why is Bayer CropSci. falling/rising?
Nov 06 2025 10:45 PM IST
share
Share Via
Is Bayer CropSci. overvalued or undervalued?
Oct 20 2025 08:06 AM IST
share
Share Via